Table 1.
Characteristics of rectal cancer patients who completed and did not complete the HRQL questionnaire
| Completers | Non-completers | |||
|---|---|---|---|---|
| Characteristic | TOTAL COMPLETERS1 N=89 (%) | FIRST-SURVEY COMPLETER2 N=71 (%) | TOTAL NON-COMPLETER3 N=56 (%) | SECOND SURVEY NON- COMPLETER4 N=34 (%) |
| Age (yr) mean | 65.0 (10.2) | 63.6 (11.8) | 68.0 (10.4) | 62.7 (12.9) |
| Gender | ||||
| Male | 46 (52%) | 43 (61%) | 36 (64%) | 20 (59%) |
| Female | 43 (48%) | 28 (39%) | 20 (36%) | 14 (41%) |
| Race | ||||
| Non-Hispanic White | 72 (81%) | 53 (75%) | 36 (64%) | 26 (76%) |
| Hispanic | 2 (2%) | 6 (5%) | 4 (7%) | 3 (9%) |
| Non-Hispanic Black | 7 (8%) | 4 (5%) | 7 (13%) | 1 (3%) |
| Asian/Pacific Islander | 8 (9%) | 8 (11%) | 9 (16%) | 4 (12%) |
| AJCC stage | ||||
| I | 34 (38%) | 19 (27%) | 18 (32%) | 10 (29%) |
| II | 22 (25%) | 19 (27%) | 17 (30%) | 9 (27%) |
| III | 28 (31%) | 28 (39%) | 15 (27%) | 13 (38%) |
| IV | 5 (6%) | 5 (7%) | 6 (11%) | 2 (6%) |
| Location in rectum | ||||
| Upper | 22 (25%) | 15 (21%) | Unknown6 | 4 (12%) |
| Middle | 28 (31%) | 25 (35%) | Unknown | 17 (50%) |
| Lower | 20 (22%) | 16 (23%) | Unknown | 6 (18%) |
| Unknown5 | 19 (21%) | 15 (21%) | Unknown | 7 (20%) |
| Surgery | ||||
| Sphincter-sparing | 62 (70%) | 48 (68%) | 43 (77%) | 23 (68%) |
| Sphincter-ablating | 27 (30%) | 23 (32%) | 13 (23%) | 11 (32%) |
| Adjuvant treatment | ||||
| Pre-operative radiation +chemotherapy | 18 (20%) | 10 (14%) | 6 (11%) | 5 (15%) |
| Post-operative radiation +chemotherapy | 31 (35%) | 29 (41%) | 17 (30%) | 12 (35%) |
| Radiation only | 1 (1%) | 4 (6%) | 0 (0%) | 3 (9%) |
| Chemotherapy only | 3 (4%) | 2 (3%) | 4 (7%) | 1 (3%) |
| None | 36 (40%) | 26 (37%) | 29 (52%) | 13 (38%) |
1
TOTAL COMPLETERS: Completed the first and follow-up surveys
2
FIRST-SURVEY COMPLETER Completed the first survey only (includes those who were invited and not invited to complete the second survey)
3
TOTAL NON-COMPLETER Did not complete any survey
4
SECOND SURVEY NON- COMPLETER Was invited to complete the follow-up survey but did not participate
5
Although a majority CCR text records have location of tumor data, this data is not required by the CCR.
6
We did not have identifiers for participants who did not respond to the survey.